Zhang Qiuning,Lyu Qingfang,Liu Ruifeng,Tian Jinhui,Yang Suisheng,Wei Shihong,Luo Hongtao,Bai Xiaorong,Bao Weiyu,Wang Xiaohu.Meta-analysis on survival rate after post-mastectomy radiotherapy for breast cancer patients with T1-T2 and 1-3 positive lymph nodes[J].Chinese Journal of Radiological Medicine and Protection,2015,35(8):598-602
Meta-analysis on survival rate after post-mastectomy radiotherapy for breast cancer patients with T1-T2 and 1-3 positive lymph nodes
Received:January 08, 2015  
DOI:10.3760/cma.j.issn.0254-5098.2015.08.009
KeyWords:Breast cancer  Axillary lymph nodes  Radiotherapy  Efficacy  Meta-analysis
FundProject:
Author NameAffiliationE-mail
Zhang Qiuning Department of Radiation Oncology, Gansu Provincial Cancer Hospital, Lanzhou 730097, China  
Lyu Qingfang 兰州大学附属第一临床医学院研究生院  
Liu Ruifeng Department of Radiation Oncology, Gansu Provincial Cancer Hospital, Lanzhou 730097, China  
Tian Jinhui Department of Radiation Oncology, Gansu Provincial Cancer Hospital, Lanzhou 730097, China  
Yang Suisheng Department of Radiation Oncology, Gansu Provincial Cancer Hospital, Lanzhou 730097, China  
Wei Shihong Department of Radiation Oncology, Gansu Provincial Cancer Hospital, Lanzhou 730097, China  
Luo Hongtao Department of Radiation Oncology, Gansu Provincial Cancer Hospital, Lanzhou 730097, China  
Bai Xiaorong Department of Radiation Oncology, Gansu Provincial Cancer Hospital, Lanzhou 730097, China  
Bao Weiyu Department of Radiation Oncology, Gansu Provincial Cancer Hospital, Lanzhou 730097, China  
Wang Xiaohu Department of Radiation Oncology, Gansu Provincial Cancer Hospital, Lanzhou 730097, China xhwanggansu@163.com 
Hits: 3083
Download times: 2413
Abstract::
      Objective To comprehensively assess the effectiveness of post-mastectomy radiotherapy (PMRT) on the local control and survival of breast cancer patients with T1-T2 and 1-3 positive axillary lymph nodes using Meta-analysis. Methods Searching the documents of the domestic and foreign medical information databases with references to other papers to identify all clinical controlled trials on post-mastectomy radiotherapy versus without irradiation for postoperative breast cancer with T1-T2 and 1-3 positive lymph nodes. Quality assessment of these studies' methodology and date extraction were conducted according to the Cochrane Reviewer's handbook 5.2. Meta-analysis was performed using RevMan 5.2 software. Results There were 14 studies and 4 643 patients enrolled, including 2 080 cases in PMRT group and 2 563 in no- PMRT group. The Meta-analysis showed that there was a significant benefit for PMRT on overall survival rate (OR 1.89, 95% CI 1.55-2.31, P<0.05), disease-free survival (OR 2.16, 95% CI 1.80-2.60, P<0.05), while decreasing the risk of locoregional recurrence (OR 0.22, 95% CI 0.16-0.30, P<0.05) and distant metastasis rate (OR 0.57, 95% CI 0.35-0.94,P<0.05). For further subset analysis, there are statistical significance between ages <40 and ≥40 (OR 0.15,95%CI 0.05-0.48;OR 0.33,95%CI 0.13-0.80,P<0.05), stages T1 and T2 (OR 0.48,95%CI 0.24-0.96; OR 0.53,95%CI 0.32-0.89,P<0.05) in breast cancer. Conclusions PMRT has benefit for overall survival rate, disease-free survival and significantly reduces the locoregional recurrence rate, distant metastasis rate in patients with T1-T2 tumors with 1-3 positive nodes. PMRT should be considered for patients with T1-T2 tumors with 1-3 positive nodes.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9073140  On-line:0

v
Scan QR Code
&et=3218C789B0E2BC6AC3CF66724139B48577D3ADC1EBEBE27827C129314AF8464302A065BEC92EDE265F8513134102218D49C9CDCFA1542BC56563C9C7B827E0C735C09609BE27E3DE7FB376424D09F401FC73403AF196F50BF9EA4F191E4D59D7B005C4E8FC69E2D2C782D0FAF4202FA6D7F02D0268F23A2BF176897D6AFA66173BAA26F0F9432EE313C795D0DC38B12064AB4BE250FB1496D076DCA4EDD2553A&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=FFD10F7019FAA9EC&aid=E22DE29B50352613BCD12AFA50A5147E&vid=&iid=5D311CA918CA9A03&sid=4720E9D07E8A2290&eid=3B2BF7AC5674E8E2&fileno=20150809&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="FFD10F7019FAA9EC"; var my_aid="E22DE29B50352613BCD12AFA50A5147E";